Stuart K Roberts
Overview
Explore the profile of Stuart K Roberts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
189
Citations
2407
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Abdelmalak J, Strasser S, Ngu N, Dennis C, Sinclair M, Majumdar A, et al.
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272868
Percutaneous ablation is recommended in Barcelona Clinic Liver Cancer (BCLC) stage 0/A patients with HCC ≤3 cm as a curative treatment modality alongside surgical resection and liver transplantation. However, trans-arterial...
12.
Sualeheen A, Tan S, Georgousopoulou E, Daly R, Tierney A, Roberts S, et al.
Nutr Bull
. 2024 Sep;
49(4):444-462.
PMID: 39258424
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease worldwide, affecting 30% of the population in Western countries. MASLD is considered the hepatic manifestation of the metabolic...
13.
Clayton-Chubb D, Majeed A, Roberts S, Schneider H, Commins I, Fitzpatrick J, et al.
J Gerontol A Biol Sci Med Sci
. 2024 Aug;
79(11).
PMID: 39158565
Background: Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are commonly ordered tests in general medical practice. However, their distribution and significance in older adults are understudied. As such, we aimed...
14.
Howell J, Combo T, Binks P, Bragg K, Bukulatjpi S, Campbell K, et al.
Med J Aust
. 2024 Aug;
221(5):230-235.
PMID: 39107943
No abstract available.
15.
Clark P, Valery P, Strasser S, Weltman M, Thompson A, Levy M, et al.
Drug Alcohol Rev
. 2024 Aug;
43(6):1559-1572.
PMID: 39091194
Introduction: Alcohol use is common in patients with chronic hepatitis C virus (HCV) infection. We examined the impact of alcohol use on direct-acting antiviral (DAA) therapy outcome and the clinical...
16.
Zandavi S, Kim C, Goodwin T, Thilakanathan C, Bostanara M, Akon A, et al.
Liver Int
. 2024 Jul;
44(10):2724-2737.
PMID: 39046171
Background: Hepatocellular carcinoma (HCC) recurrence following surgical resection remains a significant clinical challenge, necessitating reliable predictive models to guide personalised interventions. In this study, we sought to harness the power...
17.
Younossi Z, Alqahtani S, Funuyet-Salas J, Romero-Gomez M, Yilmaz Y, Keklikkiran C, et al.
JHEP Rep
. 2024 Jul;
6(7):101066.
PMID: 39022387
Background & Aims: Patients with nonalcoholic fatty liver disease (NAFLD)/metabolic dysfunction-associated steatotic liver disease (MASLD) face a multifaceted disease burden which includes impaired health-related quality of life (HRQL) and potential...
18.
George E, Sood S, Uddin R, Roberts S, Islam S
Intern Med J
. 2024 Jul;
54(8):1409-1413.
PMID: 39016076
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease. Global Burden of Disease (GBD) data from 1990 to 2019 reported a rise in prevalence (9-13%) in Australia, which...
19.
Janko N, Majeed A, Commins I, Gow P, Kemp W, Roberts S
Scand J Gastroenterol
. 2024 Jul;
59(9):1062-1068.
PMID: 39010734
Background And Aims: Patients with cirrhosis of the liver are in a delicate state of rebalanced haemostasis and are at risk of developing both bleeding and thrombotic complications. Conventional haemostatic...
20.
Vaz K, Kemp W, Majeed A, Lubel J, Magliano D, Glenister K, et al.
Hepatol Int
. 2024 Jul;
18(4):1135-1143.
PMID: 39008030
Background And Aims: The association between fatty liver disease (FLD) and cardiovascular disease (CVD) in an Australian context has yet to be defined. The primary aim of this study was...